Company intelligence / Profile preview

Trears

London, United Kingdom

Ownership: Private
Development stage: Other

Overview

The company has developed and validated a diagnostic test using earwax, demonstrating it is cheaper and requires less clinical time than standard blood-based biomarker tests. Their early clinical research has been published and the device is being commercialized, with ongoing academic collaborations.

Therapeutic areas: Metabolic DisordersPsychiatry
Modalities: Diagnostic deviceBiomarker test
Industry: Metabolite Diagnostics

Partnerships

The Ganesha Lab (startup accelerator/investment partnership)

Beyond the preview

Go deeper on Trears.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on Trears.

Explore the full profile